Stay updated on Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial

Sign up to get notified when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new site in Vinnytsia, Ukraine (Site 8002) and the associated investigator were added, increasing the total number of locations to 429. The inclusion/eligibility language for KAR-033 was expanded to specify consent procedures, assent, and relocation considerations.
    Difference
    0.3%
    Check dated 2026-07-09T16:58:43.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays a new revision label (v3.6.3) replacing the older label (v3.6.1). This indicates a small release update to the page's metadata.
    Difference
    0.0%
    Check dated 2026-07-02T14:23:38.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.6.1 replaces v3.6.0 on the page, indicating a small administrative update to the documentation. The substantive content and behavior remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-25T10:54:45.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ADEPT-3 study location footprint was updated to 428 locations with two new sites added (Bucharest, Romania and Xi’an, China) and the total locations increased accordingly. Additionally, several existing sites were removed, indicating adjustments to where participants may enroll.
    Difference
    0.6%
    Check dated 2026-06-18T07:29:44.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    New user guidance links were added to the page, including Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment label formatting was standardized and the page revision updated from v3.5.5 to v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-11T03:46:31.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The study record now includes new sites in Vinnytsia, Uzhhorod, Lviv, and Seoul, increasing the total number of locations to 426, and it reflects updated statuses for several local institutions (including completed/withdrawn ones) and the addition of Site 1252 in Shelby, NC.
    Difference
    0.5%
    Check dated 2026-06-03T19:51:29.000Z thumbnail image

Stay in the know with updates to Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.